Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD.
- Advertising -
This latest research report Lysosomal Storage Disease Market discusses the major growth drivers, key tends & developments and challenges of the market, covering the global market. The report profiles the key players of the market including Pfizer Inc., Sanofi S.A., Shire Plc and Protalix BioTherapeutics, Inc.
This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder.
- Advertising -
Further Lipid Metabolism Disorder is categorized into Gaucher disease & Fabry disease and Glycoprotein Metabolism Disorder into Pompe disease.
LSD develops mainly due to deficiency of lysosomal enzyme in the living body. A person suffering from LSD could experience problems like abnormal growth of bones, delay movement of body, deafness, blindness, dementia, respiratory problems, fatigue/weakness, bone & joint deformity, organ enlargement, lung dysfunction, severe & fatal physical & mental health deterioration.
The global LSD market is expected to grow with growing Ashkenazi (Eastern and Western Europe) population, increasing pharmaceutical R&D spending, growing disposable income, rising healthcare expenditure and accelerating economic growth. Key trends of this rare disease market includes progressing drugs under pipeline and increasing preference towards gene therapy.
However, there are some factors which can hinder growth of the market including stringent regulations and limited access to patent rights.
The report “Global Lysosomal Storage Disease (LSD) Market (Fabry, Gaucher & Pompe): Industry Analysis & Outlook (2018-2022)” provides an extensive research and detailed analysis of the present market along with future outlook.
Complete report on Lysosomal Storage Disease Market spread across 68 pages with providing 4 company profiles, 6 table and 34 charts is now available at www.marketreportsonline.com/737799.html.
Few Points from List of Tables & Charts:
List of Tables
Drugs under Development for Lysosomal Storage Disease (2017)
Global LSD Market Key Players - Revenue Comparison (2017)
Global LSD Market-Annual Treatment Cost Comparison by Company (2017)
Pfizer Inc. Significant Agreements (2017/2018)
Sanofi S.A. Significant Acquisitions (2017/2018)
Protalix BioTherapeutics, Inc. Product Pipeline (2017)
List of Charts
Classification of Lysosomal Storage Disease (LSD)
Categories of Gaucher Disease by Clinical Types
Global LSD Market Forecast by Value (2017-2022)
Global LSD Market Value by Category (2017)
Global Fabry Disease Market Forecast by Value (2017-2022)
Global Fabry Disease Market Value by Drugs (2017)
Global Fabrazyme Sales Value (2017-2022)
Global Replagal Sales Value (2017-2022)
Global Galafold Sales Value (2017-2022)
Global Gaucher Disease Market Forecast by Value (2017-2022)
Global Gaucher Disease Market Value by Drugs (2017)
Global Cerezyme Sales Value (2017-2022)
Global Vipriv Sales Value (2017-2022)
Category: Market Research Publishers and RetailersCompany about: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.